AIDS in an HIV-seronegative Ghanaian woman with intersubtype A/G recombinant HIV-1 infection.
A 29-year-old Ghanaian woman who developed AIDS while being HIV-antibody seronegative was investigated during a collaborative study aimed at the identification of viral causes of a HIV-seronegative AIDS syndrome in West Africa. Plasma was screened with a panel of EIA tests for antibodies to HIV and HIV-1 p24 antigen. Retroviral infection was investigated by detection of reverse transcriptase (RT) activity in plasma, viral RNA amplification and quantification, and virus isolation. Positive amplification products were sequenced and phylogenetic analyses were carried out. Most EIA tests were unable to demonstrate the presence of anti-HIV anti-bodies, whereas confirmatory assays yielded inconclusive results. Retroviral infection was documented by detection of RT activity, HIV-1-specific genomic amplification and virus isolation. This virus was HIV-1 subtype A with an unusual six amino acid insertion in the gp120 V4 loop and with the nef gene of subtype G. The patient's plasma did not react with either autologous or heterologous viral lysates or HIV-1 peptides, whereas antibodies to other viral antigens were present. In conclusion, the Ghanaian patient exhibited a rare subtype A/G recombinant HIV-1 infection with a near absence of a HIV-specific humoral response. The lack of detectable antibody response might be due to either a highly pathogenic, rapidly fatal, HIV-1 infection preventing the development of the typical humoral immune response or to a host-related dysfunction of the immune system. Direct antigenemia or genomic detection of the virus should be undertaken when clinical or biological data suggests an HIV infection in the absence of serological evidence.
Department of Haematology, University of Cambridge, United Kingdom.
D
D
Candotti
Y
Y
Adu-Sarkodie
F
F
Davies
E
E
Baldrich-Rubio
K
K
Stirrups
H
H
Lee
J P
JP
Allain
D000163:Acquired Immunodeficiency Syndrome / Q000175:diagnosis / Q000276:immunology / Q000821:virology*; D000328:Adult; D000595:Amino Acid Sequence; D015153:Blotting, Western; D018791:CD4 Lymphocyte Count; D005260:Female; D015693:Gene Products, nef / Q000097:blood; D005838:Genotype; D005869:Ghana; D015483:HIV Antibodies / Q000097:blood; D016655:HIV Core Protein p24 / Q000097:blood; D015699:HIV Envelope Protein gp120 / Q000097:blood; D054303:HIV Reverse Transcriptase / Q000097:blood; D018023:HIV Seronegativity / Q000235:genetics*; D015497:HIV-1 / Q000235:genetics* / Q000302:isolation & purification; D006680:HLA Antigens / Q000097:blood; D006801:Humans; D007124:Immunoenzyme Techniques; D008969:Molecular Sequence Data; D012367:RNA, Viral / Q000097:blood; D011995:Recombination, Genetic; D020133:Reverse Transcriptase Polymerase Chain Reaction; D016415:Sequence Alignment; D054311:nef Gene Products, Human Immunodeficiency Virus
D015693:Gene Products, nef; D015483:HIV Antibodies; D016655:HIV Core Protein p24; D015699:HIV Envelope Protein gp120; D006680:HLA Antigens; D012367:RNA, Viral; D054311:nef Gene Products, Human Immunodeficiency Virus; D054303:HIV Reverse Transcriptase